Striatal expression of substance P and methionin-enkephalin in genes in patients with Parkinson's disease.
The striatal expression of substance P (SP) and methionin-enkephalin (met-enk) genes was studied post mortem by in situ hybridization in patients with Parkinson's disease and a group of control subjects. No significant difference in striatal expression of these two neuropeptide messenger RNAs (mRNAs) was found in the patients compared with control subjects. This contrasts with animal models of parkinsonism, where expression of SP mRNA is decreased and met-enk mRNA increased. Possible explanations include: (1) compensatory mechanisms, which may develop during the long term evolution of Parkinson's disease; (2) normalized expression of the two genes resulting from chronic L-DOPA therapy.
Levy
R
R
INSERM U289, Hôpital de la Salpêtrière, Paris, France.
Vila
M
M
Herrero
M T
MT
Faucheux
B
B
Agid
Y
Y
Hirsch
E C
EC
D000368:Aged; D002421:Caudate Nucleus / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism*; D004744:Enkephalin, Methionine / Q000235:genetics*; D006801:Humans; D017403:In Situ Hybridization; D010300:Parkinson Disease / Q000235:genetics / Q000378:metabolism*; D011699:Putamen / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D013373:Substance P / Q000235:genetics / Q000378:metabolism*
D012333:RNA, Messenger; D013373:Substance P; D004744:Enkephalin, Methionine